Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 20, 2026
Expenses
$110,000
What this organization spent lobbying with its own staff.
Reported using the LDA's own definitions (method A): the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
District of Columbia
Government bodies contacted
2
Lobbying activity
3
H.R.6248 - Healthy Competition for Better Care Act S.4027 - Healthy Competition for Better Care Act H.R.9393 - Lower Costs, More Transparency Act H.R.9693 - Patients First Act S.2355 - Patients Deserve Price Tags Act
S.1954 - Biosimilar Red Tape Elimination Act
Matters related to reforming Medicare quality